
China
3.6
Guizhuang Industry Park, Taicang
Add Favorite
Report Supplier
Business Description
Kanghui Medical Technology (Suzhou) Co., Ltd. Was established in 1998. It provides product research and development, planning consultation, design and manufacturing, sales and after-sales service. It is a high-tech company whose products focus on ICU intelligent nursing bed, Electric L. D. R bed, Delivery bed, as well as aged care assistive equipment in medical and rehabilitation field.
Kanghui gets the management system certifications in respect of quality, environment, occupational health, intellectual property rights, and the informational & industrial integration. Meanwhile, it also FDA registered and CE certified.
In 2021, the intelligent manufacturing equipment made by TRUMPF Germany was introduced, which enable Kanghui's manufacturing mode to transform into digital, intelligent and automated mode, and greatly enhance the core competitiveness of the company.
After more than 20 years of market competition and development, the company has successfully operated two major brands of "COMBED" obstetrics and gynecology equipment and "JIU JIU YAN YANG" elderly products, established a two-wheel drive business model, and formed a relatively mature industrial chain of Product-Service- Overall Solution.
Export Capabilities
Declared by supplierKANGHUI MEDICAL TECHNOLOGY(SUZHOU)CO., LTD. has been exporting since 2000. The company ships out of the Port of Shanghai Port.
Export start year
2000
Logistics and terms accepted
Trade Capabilities
Business Terms
Trade Ability
ICU Ventilator market insight
Across Medical & HealthCare, the wider group ICU Ventilator belongs to, Freshdi lists 9 active supply listings from 9 suppliers in 6 countries, as of 18 November 2026. ICU Ventilator belongs to Medical & HealthCare, whose suppliers on Freshdi come from 6 countries, led by India at 22.2%, as of 18 November 2026. Buyer inquiry volume across Medical & HealthCare, the wider group ICU Ventilator belongs to, rose 100% on Freshdi in the 30 days to 18 November 2026 against the 30 days before, with 103.41% volatility in monthly inquiry and quotation activity over 338 days.
